50 results on '"Asquith, Becca"'
Search Results
2. Quantifying the Impact of Human Immunodeficiency Virus-1 Escape From Cytotoxic T-Lymphocytes.
- Author
-
Kadolsky, Ulrich D. and Asquith, Becca
- Subjects
- *
LYMPHOCYTE metabolism , *HIV , *CELL-mediated cytotoxicity , *VIRAL load , *T cells , *CHRONIC diseases - Abstract
HIV-1 escape from the cytotoxic T-lymphocyte (CTL) response leads to a weakening of viral control and is likely to be detrimental to the patient. To date, the impact of escape on viral load and CD4+ T cell count has not been quantified, primarily because of sparse longitudinal data and the difficulty of separating cause and effect in cross-sectional studies. We use two independent methods to quantify the impact of HIV-1 escape from CTLs in chronic infection: mathematical modelling of escape and statistical analysis of a cross-sectional cohort. Mathematical modelling revealed a modest increase in log viral load of 0.051 copies ml-1 per escape event. Analysis of the cross-sectional cohort revealed a significant positive association between viral load and the number of ''escape events'', after correcting for length of infection and rate of replication. We estimate that a single CTL escape event leads to a viral load increase of 0.11 log copies ml-1 (95% confidence interval: 0.040-0.18), consistent with the predictions from the mathematical modelling. Overall, the number of escape events could only account for approximately 6% of the viral load variation in the cohort. Our findings indicate that although the loss of the CTL response for a single epitope results in a highly statistically significant increase in viral load, the biological impact is modest. We suggest that this small increase in viral load is explained by the small growth advantage of the variant relative to the wildtype virus. Escape from CTLs had a measurable, but unexpectedly low, impact on viral load in chronic infection. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
3. Lymphocyte kinetics in health and disease
- Author
-
Asquith, Becca, Borghans, José A.M., Ganusov, Vitaly V., and Macallan, Derek C.
- Subjects
- *
CELLULAR immunity , *LYMPHOCYTES , *CELL division , *CELL death , *CYTOLOGY - Abstract
Quantitative understanding of immunology requires the development of experimental and mathematical techniques for estimation of rates of division and death of lymphocytes under different conditions. Here, we review the advantages and limitations of several labelling methods that are currently used to quantify turnover of lymphocytes in vivo. In addition to highlighting insights into lymphocyte kinetics which have recently been gained thanks to the development of novel techniques, we discuss important directions for future experimental and theoretical work in the field of lymphocyte turnover. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
4. The Evolutionary Selective Advantage of HIV-1 Escape Variants and the Contribution of Escape to the HLA-Associated Risk of AIDS Progression.
- Author
-
Asquith, Becca
- Subjects
- *
HIV , *LYMPHOCYTES , *IMMUNITY , *AIDS , *EPITOPES , *DATABASES , *DISEASE progression , *AIDS patients , *DATA analysis - Abstract
HIV-1 escape from surveillance by cytotoxic T lymphocytes (CTL) is thought to cause at least transient weakening of immune control. However, the CTL response is highly adaptable and the long-term consequences of viral escape are not fully understood. The objective of this study was to address the question "to what extent does HIV-1 escape from CTL contribute to HLA-associated AIDS progression?" We combined an analysis of 21 escape events in longitudinally-studied HIV-1 infected people with a population-level analysis of the functional CTL response in 150 subjects (by IFNg ELISpot) and an analysis of the HIV-1 sequence database to quantify the contribution of escape to the HLA-associated rate of AIDS progression. We found that CTL responses restricted by protective HLA class I alleles, which are associated with slow progression to AIDS, recognised epitopes where escape variants had a weak evolutionary selective advantage (P = 0.008) and occurred infrequently (P = 0.017). Epitopes presented by protective HLA class I alleles were more likely to elicit a CTL response (P = 0.001) and less likely to contain sequence variation (P = 0.006). A third of between-individual variation in HLA-associated disease risk was predicted by the selective advantage of escape variants: a doubling in the evolutionary selective advantage was associated with a decrease in the AIDS-free period of 1.2 yrs. These results contribute to our understanding of what makes a CTL response protective and why some individuals progress to AIDS more rapidly than others. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
5. How does HTLV-I persist despite a strong cell-mediated immune response?
- Author
-
Asquith, Becca and Bangham, Charles R.M.
- Subjects
- *
HIV , *T cells , *IMMUNOSUPPRESSION , *HOST-virus relationships , *RETROVIRUSES - Abstract
Human T-lymphotropic virus type 1 (HTLV-1) is a pathogenic retrovirus that infects human CD4+ T lymphocytes. Despite its presence in T cells, HTLV-1 causes little overt immunosuppression. This host-virus relationship has therefore been exploited as an excellent model system for studying the dynamic interaction between a persistent retrovirus and the normal human immune system. We use a combination of mathematical and experimental techniques to identify key factors on both sides of the in vivo host-virus interaction that significantly determine HTLV-I proviral load and disease risk. We develop a model to describe how these factors interact to enable viral persistence. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
6. Quantifying HTLV-I dynamics.
- Author
-
Asquith, Becca and Bangham, Charles R. M.
- Subjects
- *
IMMUNE response , *VIRUSES , *T cells , *HTLV-I , *MATHEMATICAL models , *INFECTION - Abstract
Despite significant advances in our understanding of the immune response to persistent viruses like human T-cell lymphotropic virus type I (HTLV-I), many important questions remain unanswered. Mathematical modelling enables us to interpret and synthesise diverse experimental data in new ways and thus can contribute to our understanding. Here, we review recent advances in mathematical modelling of HTLV-I infection and illustrate how mathematics has enabled us to identify factors that determine an individual's viral burden and risk of developing HTLV-I-associated diseases.Immunology and Cell Biology (2007) 85, 280–286; doi:10.1038/sj.icb.7100050; published online 20 March 2007 [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
7. In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection.
- Author
-
Asquith, Becca, Yan Zhang, Mosley, Angelina J., de Lara, Catherine M., Wallace, Diana L., Worth, Andrew, Kaftantzi, Lambrini, Meekings, Kiran, Griffin, George E., Yuetsu Tanaka, Toughs, David F., Beverley, Peter C., Taylor, Graham P., Macallan, Derek C., and Bangham, Charles R. M.
- Subjects
- *
T cells , *HTLV-I , *CD4 antigen , *HTLV-I infections , *CELL proliferation , *GENE expression , *RETROVIRUSES - Abstract
Human T-lymphotropic virus type 1 (HTLV-1) is a persistent CD4+ T-lymphotropic retrovirus. Most HTLV-1-infected individuals remain asymptomatic, but a proportion develop adult T cell leukemia or inflammatory disease. It is not fully understood how HTLV-1 persists despite a strong immune response or what determines the risk of HTLV-1-associated diseases. Until recently, it has been difficult to quantify lymphocyte kinetics in humans in vivo. Here, we used deuterated glucose labeling to quantify in vivo lymphocyte dynamics in HTLV-1-infected individuals. We then used these results to address four questions. (i) What is the impact of HTLV-1 infection on lymphocyte dynamics? (ii) How does HTLV-1 persist? (iii) What is the extent of HTLV-1 expression in vivo? (iv) What features of lymphocyte kinetics are associated with HTLV-1-associated myelopathy/tropical spastic paraparesis? We found that CD4+CD45RO+ and CD8+CD45RO+ T lymphocyte proliferation was elevated in HTLV-1-infected subjects compared with controls, with an extra 1012 lymphocytes produced per year in an HTLV-1-infected subject. The in vivo proliferation rate of CD4+CD45RO+ cells also correlated with ex vivo viral expression. Finally, the inflammatory disease HTLV-1-associated myelopathy/tropical spastic paraparesis was associated with significantly increased CD4+CD45RO+ cell proliferation. We suggest that there is persistent viral gene expression in vivo, which is necessary for the maintenance of the proviral load and determines HTLV-1-associated myelopathy/tropical spastic paraparesis risk. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
8. In vivo CD8+ T cell control of immunodeficiency virus infection in humans and macaques.
- Author
-
Asquith, Becca and McLean, Angela R.
- Subjects
- *
HIV , *T cells , *ANTIRETROVIRAL agents , *IMMUNE response , *MACAQUES , *SIMIAN viruses , *VIRAL replication - Abstract
Forty million people are estimated to be infected with HIV-1, and only a small fraction of those have access to life-prolonging antiretroviral treatment. As the epidemic grows there is an urgent need for effective therapeutic and prophylactic vaccines. Nonhuman primate models of immunodeficiency virus infection are essential for the preclinical evaluation of candidate vaccines. To interpret the results of these trials, comparative studies of the human and macaque immune responses are needed. Despite the widespread use of macaques to evaluate vaccines designed to elicit a CD8+ cytotoxic T lymphocyte (CTL) response, the efficiency with which CTL control immunodeficiency virus infections has not been compared between humans and macaques, largely because of difficulties in assaying the functional CTL response. We recently developed a method for estimating the rate at which CTLs kill cells productively infected with HIV-1 in humans in vivo. Here, using the same technique, we quantify the rate at which CTLs kill infected cells in macaque models of HIV infection. We show that CTLs kill productively infected cells significantly faster (P = 0.004) and that escape variants have significantly higher fitness costs (P = 0.003) in macaques compared with humans. These results suggest that it may be easier to elicit a protective CTL response in macaques than in humans and that vaccine studies conducted in macaques need to be interpreted accordingly. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
9. Inefficient Cytotoxic T Lymphocyte-Mediated Killing of HIV-1-Infected Cells In Vivo.
- Author
-
Asquith, Becca, Edwards, Charles T. T., Lipsitch, Marc, and McLean, Angela R.
- Subjects
- *
LYMPHOCYTES , *HIV infections , *VACCINE biotechnology , *HLA histocompatibility antigens , *CELL death - Abstract
Understanding the role of cytotoxic T lymphocytes (CTLs) in controlling HIV-1 infection is vital for vaccine design. However, it is difficult to assess the importance of CTLs in natural infection. Different human leukocyte antigen (HLA) class I alleles are associated with different rates of progression to AIDS, indicating that CTLs play a protective role. Yet virus clearance rates following antiretroviral therapy are not impaired in individuals with advanced HIV disease, suggesting that weakening of the CTL response is not the major underlying cause of disease progression and that CTLs do not have an important protective role. Here we reconcile these apparently conflicting studies. We estimate the selection pressure exerted by CTL responses that drive the emergence of immune escape variants, thereby directly quantifying the efficiency of HIV-1-specific CTLs in vivo. We estimate that only 2% of productively infected CD4+ cell death is attributable to CTLs recognising a single epitope. We suggest that CTLs kill a large number of infected cells (about 107) per day but are not responsible for the majority of infected cell death. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
10. Quantification of the virus-host interaction in human T lymphotropic virus I infection.
- Author
-
Asquith, Becca, Mosley, Angelina J., Heaps, Adrian, Tanaka, Yuetsu, Taylor, Graham P., McLean, Angela R., and Bangham, Charles R. M.
- Subjects
- *
ETIOLOGY of diseases , *VIRUS diseases , *IMMUNOLOGY , *HTLV-I , *HTLV , *LYMPHOCYTES - Abstract
Background: HTLV-I causes the disabling inflammatory disease HAM/TSP: there is no vaccine, no satisfactory treatment and no means of assessing the risk of disease or prognosis in infected people. Like many immunopathological diseases with a viral etiology the outcome of infection is thought to depend on the virus-host immunology interaction. However the dynamic virus-host interaction is complex and current models of HAM/TSP pathogenesis are conflicting. The CD8+ cell response is thought to be a determinant of both HTLV-I proviral load and disease status but its effects can obscure other factors. Results: We show here that in the absence of CD8+ cells, CD4+ lymphocytes from HAM/TSP patients expressed HTLV-I protein significantly more readily than lymphocytes from asymptomatic carriers of similar proviral load (P = 0.017). A high rate of viral protein expression was significantly associated with a large increase in the prevalence of HAM/TSP (P = 0.031, 89% of cases correctly classified). Additionally, a high rate of Tax expression and a low CD8+ cell efficiency were independently significantly associated with a high proviral load (P = 0.005, P = 0.003 respectively). Conclusion: These results disentangle the complex relationship between immune surveillance, proviral load, inflammatory disease and viral protein expression and indicate that increased protein expression may play an important role in HAM/TSP pathogenesis. This has important implications for therapy since it suggests that interventions should aim to reduce Tax expression rather than proviral load per se. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
11. Reduced Cell Turnover in Bovine Leukemia Virus-Infected, Persistently Lymphocytotic Cattle.
- Author
-
Debacq, Christophe, Asquith, Becca, Reichert, Michal, Burny, Arsène, Kettmann, Richard, and Willems, Luc
- Subjects
- *
BROMODEOXYURIDINE , *CELL proliferation , *NUCLEOTIDES , *VIROLOGY - Abstract
Although nucleotide analogs like bromodeoxyuridine have been extensively used to estimate cell proliferation in vivo, precise dynamic parameters are scarce essentially because of the lack of adequate mathematical models. Besides recent developments on T cell dynamics, the turnover rates of B lymphocytes are largely unknown particularly in the context of a virally induced pathological disorder. Here, we aim to resolve this issue by determining the rates of cell proliferation and death during the chronic stage of the bovine leukemia virus (BLV) infection, called bovine persistent lymphocytosis (PL). Our methodology is based on direct intravenous injection of bromodeoxyuridine in association with subsequent flow cytometry. By this in vivo approach, we show that the death rate of PL B lymphocytes is significantly reduced (average death rate, 0.057 day[sup -1] versus 0.156 day[sup -1] in the asymptomatic controls). Concomitantly, proliferation of the PL cells is also significantly restricted compared to the controls (average proliferation rate, 0.0046 day[sup -1] versus 0.0085 day[sup -1]). We conclude that bovine PL is characterized by a decreased cell turnover resulting both from a reduction of cell death and an overall impairment of proliferation. The cell dynamic parameters differ from those measured in sheep, an experimental model for BLV infection. Finally, cells expressing p24 major capsid protein ex vivo were not BrdU positive, suggesting an immune selection against proliferating virus-positive lymphocytes. Based on a comparative leukemia approach, these observations might help to understand cell dynamics during other lymphoproliferative disease such as chronic lymphocytic leukemia or human T-cell lymphotropic virusinduced adult T-cell leukemia in humans. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
12. The dynamics of T-cell fratricide: application of a robust approach to mathematical modelling in immunology
- Author
-
Asquith, Becca and Bangham, Charles R.M.
- Subjects
- *
T cells , *IMMUNOLOGY - Abstract
Fratricide between
CD8+ T lymphocytes is known to occur in HTLV-I and possibly HSV-1 and HIV-1 infection. However it is not known what effect, if any, T-cell fratricide has on the course of infection. Here we present simple mathematical techniques to investigate T-cell fratricide with particular reference to HTLV-I infection. Using a general model we predict the qualitative and quantitative effect of fratricide on HTLV-I equilibrium proviral load. We also investigate the effect of fratricide on the probability of viral clearance.We show that, surprisingly, fratricide can lead either to an increase or a decrease in equilibrium proviral load. We derive the conditions necessary for fratricide to cause a decrease in load and deduce that, for the five HTLV-I-positive patients considered here, fratricide has probably caused an increase in equilibrium load. We also estimate the percentage increase in load that is attributable to fratricide and determine the parameters that should be measured in order to improve this estimate. Finally, we show that fratricide reduces the probability of viral clearance.Mathematical modelling of HTLV-I infection, as is often the case in biology, is severely hampered by a lack of experimental data. Consequently it is difficult to know what functional form a model should take. The behaviour of complex nonlinear systems is highly model-dependent. Predictions based on theoretical models are therefore sensitive to the choice of model; this is a very severe problem that undermines and limits the success of the application of mathematics to immunology. In this paper we reduce the model dependency of the results in two ways—by considering (analytically) a general model with a minimal number of assumptions and, where this is not possible, by checking (numerically) that a wide range of models yield the same results. We therefore begin to develop two practical methods for dealing with the problem of robustness in mathematical models of the immune system. [Copyright &y& Elsevier]- Published
- 2003
- Full Text
- View/download PDF
13. Lymphocyte kinetics: the interpretation of labelling data
- Author
-
Asquith, Becca, Debacq, Christophe, Macallan, Derek C., Willems, Luc, and Bangham, Charles R.M.
- Subjects
- *
DNA , *LYMPHOCYTES - Abstract
DNA labelling provides an exciting tool for elucidating the in vivo dynamics of lymphocytes. However, the kinetics of label incorporation and loss are complex and results can depend on the method of interpretation. Here we describe two approaches to interpreting labelling data. Both seek to explain the common observation that the estimated death rate of lymphocytes is higher than their estimated proliferation rate. In the first approach, an additional source of lymphocytes is postulated. In the second, it is maintained that lymphocyte heterogeneity is sufficient to account for the observation. We explain why we favour the second approach, arguing that the addition of a large source of lymphocytes is unnecessary and difficult to reconcile with what is currently known about lymphocyte physiology. We discuss how the choice of model can affect data interpretation. [ABSTRACT FROM AUTHOR]
- Published
- 2002
- Full Text
- View/download PDF
14. Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep.
- Author
-
Debacq, Christophe, Asquith, Becca, Kerkhofs, Pierre, Portetelle, Daniel, Burny, Arsène, Kettmann, Richard, and Willems, Luc
- Subjects
- *
CELL proliferation , *APOPTOSIS , *T cells , *BOVINE leukemia virus - Abstract
Examines the importance of cell proliferation versus apoptosis during pathogenesis induced by the promate T cell lymphotropic viruses and bovine leukemia virus. Measurement of the rates of cell proliferation and death; Role of the increase in the number of B cells; Complexity in the mechanism of feedback regulation controlling homeostasis.
- Published
- 2002
- Full Text
- View/download PDF
15. KIR-HLA interactions extend human CD8+ T cell lifespan in vivo.
- Author
-
Yan Zhang, Yan, Ada W. C., Boelen, Lies, Hadcocks, Linda, Salam, Arafa, Gispert, Daniel Padrosa, Spanos, Loiza, Bitria, Laura Mora, Nemat-Gorgani, Neda, Traherne, James A., Roberts, Chrissy, Koftori, Danai, Taylor, Graham P., Forton, Daniel, Norman, Paul J., Marsh, Steven G. E., Busch, Robert, Macallan, Derek C., and Asquith, Becca
- Subjects
- *
T cells , *KILLER cell receptors , *SCHOLARSHIPS , *SOCIAL interaction , *IMMUNOLOGIC memory - Abstract
BACKGROUND. There is increasing evidence, in transgenic mice and in vitro, that inhibitory killer cell immunoglobulin-like receptors (iKIRs) can modulate T cell responses. Furthermore, we have previously shown that iKIRs are an important determinant of T cell--mediated control of chronic viral infection and that these results are consistent with an increase in the CD8+ T cell lifespan due to iKIR-ligand interactions. Here, we tested this prediction and investigated whether iKIRs affect T cell lifespan in humans in vivo. METHODS. We used stable isotope labeling with deuterated water to quantify memory CD8+ T cell survival in healthy individuals and patients with chronic viral infections. RESULTS. We showed that an individual's iKIR-ligand genotype was a significant determinant of CD8+ T cell lifespan: in individuals with 2 iKIR-ligand gene pairs, memory CD8+ T cells survived, on average, for 125 days; in individuals with 4 iKIR- ligand gene pairs, the memory CD8+ T cell lifespan doubled to 250 days. Additionally, we showed that this survival advantage was independent of iKIR expression by the T cell of interest and, further, that the iKIR-ligand genotype altered the CD8+ and CD4+ T cell immune aging phenotype. CONCLUSIONS. Together, these data reveal an unexpectedly large effect of iKIR genotype on T cell survival. FUNDING. Wellcome Trust; Medical Research Council; EU Horizon 2020; EU FP7; Leukemia and Lymphoma Research; National Institute of Health Research (NIHR) Imperial Biomedical Research Centre; Imperial College Research Fellowship; National Institutes of Health; Jefferiss Trust. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
16. Susceptibility of HBZ and Tax expressing primary HTLV-1+ T cell clones to CTL lysis.
- Author
-
Rowan, Aileen G., Asquith, Becca, Taylor, Graham P., and Bangham, Charles R. M.
- Subjects
- *
HTLV - Abstract
An abstract of the article "Susceptibility of HBZ and Tax Expressing Primary HTLV-1+ T Cell Clones to CTL Lysis," by Aileen G Rowan from 15th International Conference on Human Retroviruses: HTLV and Related Viruses Leuven and Gembloux held in Belgium from June 5-8, 2011 is presented.
- Published
- 2011
- Full Text
- View/download PDF
17. Corrigendum: Lymphocyte kinetics in health and disease: [Trends Immunol. 30 (2009), 182-189]
- Author
-
Asquith, Becca, Borghans, José A.M., Ganusov, Vitaly V., and Macallan, Derek C.
- Published
- 2009
- Full Text
- View/download PDF
18. Estimating T-cell repertoire diversity: limitations of classical estimators and a new approach.
- Author
-
Laydon, Daniel J., Bangham, Charles R. M., and Asquith, Becca
- Subjects
- *
T-cell receptor genes , *IMMUNE system , *VIRUS diseases , *IMMUNOLOGY , *T cells - Abstract
A highly diverse T-cell receptor (TCR) repertoire is a fundamental property of an effective immune system, and is associated with efficient control of viral infections and other pathogens. However, direct measurement of total TCR diversity is impossible. The diversity is high and the frequency distribution of individual TCRs is heavily skewed; the diversity therefore cannot be captured in a blood sample. Consequently, estimators of the total number of TCR clono-types that are present in the individual, in addition to those observed, are essential. This is analogous to the 'unseen species problem' in ecology. We review the diversity (species richness) estimators that have been applied to T-cell repertoires and the methods used to validate these estimators. We show that existing approaches have significant shortcomings, and frequently under-estimate true TCR diversity. We highlight our recently developed estimator, DivE, which can accurately estimate diversity across a range of immunological and biological systems. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
19. The Efficiency of the Human CD8+ T Cell Response: How Should We Quantify It, What Determines It, and Does It Matter?
- Author
-
Elemans, Marjet, Basatena, Nafisa-Katrin Seich al, and Asquith, Becca
- Subjects
- *
CD8 antigen , *T cells , *EXPERIMENTAL immunology , *IMMUNITY , *EPITOPES , *PERSISTENT viral diseases , *HLA histocompatibility antigens - Abstract
Multidisciplinary techniques, in particular the combination of theoretical and experimental immunology, can address questions about human immunity that cannot be answered by other means. From the turnover of virus-infected cells in vivo, to rates of thymic production and HLA class I epitope prediction, theoretical techniques provide a unique insight to supplement experimental approaches. Here we present our opinion, with examples, of some of the ways in which mathematics has contributed in our field of interest: the efficiency of the human CD8+ T cell response to persistent viruses. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
20. Earlier Onset of δ-Retrovirus-Induced Leukemia after Splenectomy.
- Author
-
Florins, Arnaud, Reichert, Michal, Asquith, Becca, Bouzar, Amel-Baya, Jean, Geneviève, François, Carole, Jasik, Agnieszka, Burny, Arsène, Kettmann, Richard, and Willems, Luc
- Subjects
- *
RETROVIRUSES , *LEUKEMIA , *SPLENECTOMY , *INFECTION , *LYMPHOPROLIFERATIVE disorders , *NEURODEGENERATION - Abstract
Infection by d-retroviruses such as human T-lymphotropic virus type 1 (HTLV-1) and bovine leukemia virus (BLV) is mostly asymptomatic. Indeed, only a minority (<5%) of d-retrovirus infected hosts will develop either lymphoproliferative or neurodegenerative diseases after long latency periods. In fact, the host immune response is believed to tightly control viral replication but this assumption has not been definitely proven in vivo. Here, we provide direct experimental evidence demonstrating that integrity of the spleen is required to control pathogenesis. In the BLV model, we show that asplenia decreases efficiency of the immune response and induces an imbalance in cell dynamics resulting in accelerated onset of leukemia. These observations enlighten a potential threat in splenectomized HTLV-1 carriers and justify a regular preventive evaluation. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
21. Reduction of B cell turnover in chronic lymphocytic leukaemia.
- Author
-
Defoiche, Julien, Debacq, Christophe, Asquith, Becca, Zhang, Yan, Burny, Arsène, Bron, Dominique, Lagneaux, Laurence, Macallan, Derek, and Willems, Luc
- Subjects
- *
B cells , *CHRONIC lymphocytic leukemia , *LYMPHOCYTES , *CELL proliferation , *DEUTERIUM - Abstract
Whether chronic lymphocytic leukaemia (CLL) is a latent or a proliferating disease has been intensively debated. Whilst the dogma that CLL results from accumulation of dormant lymphocytes is supported by the unresponsiveness of leukaemic cells to antigens and polyclonal activators, recent in vivo kinetic measurements indicate that B lymphocytes do divide at significant rates in CLL. However, an important and still unanswered question is whether CLL cells proliferate faster or slower compared with their normal counterparts. This report addressed directly this point and compared B-cell kinetics in CLL subjects and healthy controls, using a pulse-chase approach based on incorporation of deuterium from 6,6-2H2-glucose into DNA. We confirmed that B cells proliferated at significant levels in CLL but found that the proliferation rates were reduced compared with healthy subjects (mean 0·47 vs. 1·31%/d respectively, P = 0·007), equivalent to an extended doubling time of circulating B cells (147 d vs. 53 d). In conclusion, CLL B cells proliferate at reduced levels compared with healthy controls. CLL is thus characterized by an aberrant B-cell kinetics with a decrease in cell turnover, an observation that may impact on elaboration of efficient therapeutic strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
22. Reduced cell turnover in lymphocytic monkeys infected by human T-lymphotropic virus type 1.
- Author
-
Debacq, Christophe, Héraud, Jean-Michel, Asquith, Becca, Bangham, Charles, Merien, Fabrice, Moules, Vincent, Mortreux, Franck, Wattel, Eric, Burny, Arsène, Kettmann, Richard, Kazanji, Mirdad, and Willems, Luc
- Subjects
- *
LEUKEMIA , *ADULT T-cell leukemia , *THERAPEUTICS , *LEUKEMIA diagnosis , *HTLV , *BROMODEOXYURIDINE - Abstract
Understanding cell dynamics in animal models have implications for therapeutic strategies elaborated against leukemia in human. Quantification of the cell turnover in closely related primate systems is particularly important for rare and aggressive forms of human cancers, such as adult T-cell leukemia. For this purpose, we have measured the death and proliferation rates of the CD4+ T lymphocyte population in squirrel monkeys (Saimiri sciureus) infected by human T-lymphotropic virus type 1 (HTLV-1). The kinetics of in vivo bromodeoxyuridine labeling revealed no modulation of the cell turnover in HTLV-1-infected monkeys with normal CD4 cell counts. In contrast, a substantial decrease in the proliferation rate of the CD4+ T population was observed in lymphocytic monkeys (e.g. characterized by excessive proportions of CD4+ T lymphocytes and by the presence of abnormal flower-like cells). Unexpectedly, onset of HTLV-associated leukemia thus occurs in the absence of increased CD4+ T-cell proliferation. This dynamics significantly differs from the generalized activation of the T-cell turnover induced by other primate lymphotropic viruses like HIV and SIV.Oncogene (2005) 24, 7514–7523. doi:10.1038/sj.onc.1208896; published online 8 August 2005 [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
23. The relative contributions of infectious and mitotic spread to HTLV-1 persistence.
- Author
-
Laydon, Daniel J., Sunkara, Vikram, Boelen, Lies, Bangham, Charles R. M., and Asquith, Becca
- Subjects
- *
ADULT T-cell leukemia , *HTLV , *STOCHASTIC processes , *ANTIRETROVIRAL agents , *CLONE cells - Abstract
Human T-lymphotropic virus type-1 (HTLV-1) persists within hosts via infectious spread (de novo infection) and mitotic spread (infected cell proliferation), creating a population structure of multiple clones (infected cell populations with identical genomic proviral integration sites). The relative contributions of infectious and mitotic spread to HTLV-1 persistence are unknown, and will determine the efficacy of different approaches to treatment. The prevailing view is that infectious spread is negligible in HTLV-1 persistence beyond early infection. However, in light of recent high-throughput data on the abundance of HTLV-1 clones, and recent estimates of HTLV-1 clonal diversity that are substantially higher than previously thought (typically between 104 and 105 HTLV-1+ T cell clones in the body of an asymptomatic carrier or patient with HTLV-1-associated myelopathy/tropical spastic paraparesis), ongoing infectious spread during chronic infection remains possible. We estimate the ratio of infectious to mitotic spread using a hybrid model of deterministic and stochastic processes, fitted to previously published HTLV-1 clonal diversity estimates. We investigate the robustness of our estimates using three alternative estimators. We find that, contrary to previous belief, infectious spread persists during chronic infection, even after HTLV-1 proviral load has reached its set point, and we estimate that between 100 and 200 new HTLV-1 clones are created and killed every day. We find broad agreement between all estimators. The risk of HTLV-1-associated malignancy and inflammatory disease is strongly correlated with proviral load, which in turn is correlated with the number of HTLV-1-infected clones, which are created by de novo infection. Our results therefore imply that suppression of de novo infection may reduce the risk of malignant transformation. Author summary: There is no effective antiretroviral treatment for infection with Human T-lymphotropic virus type-1 (HTLV-1), which causes a range of inflammatory diseases and the aggressive malignancy Adult T-cell Leukaemia/Lymphoma (ATL) in approximately 10% of infected people. Within hosts the virus spreads via infectious spread (de novo infection) and mitotic spread (infected cell division). The relative contributions of each mechanism are unknown, and have major implications for drug development and clinical management of infection. We estimate the ratio of infectious to mitotic spread during the infection's chronic phase using three methods. Each method indicates infectious spread at low but persistent levels after proviral load has reached set point, contrary to the prevailing view that infectious spread features in early infection only. Risk of disease in HTLV-1 infection is known to increase with proviral load, via mutations accrued from repeated infected cell division. Our analyses suggest that ongoing infectious spread may provide an additional mechanism whereby chronic infection becomes malignant. Further, because antiretroviral drugs against Human Immunodeficiency Virus (HIV) inhibit HTLV-1 infectious spread, they may reduce the risk of HTLV-1 malignancy. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
24. Human TSCM cell dynamics in vivo are compatible with long-lived immunological memory and stemness.
- Author
-
del Amo, Pedro Costa, Beneytez, Julio Lahoz, Boelen, Lies, Ahmed, Raya, Miners, Kelly L., Zhang, Yan, Roger, Laureline, Jones, Rhiannon E., Marraco, Silvia A. Fuertes, Speiser, Daniel E., Baird, Duncan M., Price, David A., Ladell, Kristin, Macallan, Derek, and Asquith, Becca
- Subjects
- *
T cells , *IMMUNE system , *TELOMERES , *LYMPHOCYTES , *IMMUNOLOGY - Abstract
Adaptive immunity relies on the generation and maintenance of memory T cells to provide protection against repeated antigen exposure. It has been hypothesised that a self-renewing population of T cells, named stem cell–like memory T (TSCM) cells, are responsible for maintaining memory. However, it is not clear if the dynamics of TSCM cells in vivo are compatible with this hypothesis. To address this issue, we investigated the dynamics of TSCM cells under physiological conditions in humans in vivo using a multidisciplinary approach that combines mathematical modelling, stable isotope labelling, telomere length analysis, and cross-sectional data from vaccine recipients. We show that, unexpectedly, the average longevity of a TSCM clone is very short (half-life < 1 year, degree of self-renewal = 430 days): far too short to constitute a stem cell population. However, we also find that the TSCM population is comprised of at least 2 kinetically distinct subpopulations that turn over at different rates. Whilst one subpopulation is rapidly replaced (half-life = 5 months) and explains the rapid average turnover of the bulk TSCM population, the half-life of the other TSCM subpopulation is approximately 9 years, consistent with the longevity of the recall response. We also show that this latter population exhibited a high degree of self-renewal, with a cell residing without dying or differentiating for 15% of our lifetime. Finally, although small, the population was not subject to excessive stochasticity. We conclude that the majority of TSCM cells are not stem cell–like but that there is a subpopulation of TSCM cells whose dynamics are compatible with their putative role in the maintenance of T cell memory. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
25. Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 with C2+ HLA-C in Two Indigenous Human Populations in Southern Africa.
- Author
-
Nemat-Gorgani, Neda, Hilton, Hugo G., Parham, Peter, Norman, Paul J., Nobuyo Yawata, Makoto Yawata, Boelen, Lies, Asquith, Becca, Henn, Brenna M., Meng Lin, Myrick, Justin W., Gignoux, Christopher R., Werely, Cedric J., Möller, Marlo, Hoal, Eileen G., and Granka, Julie M.
- Subjects
- *
INDIGENOUS peoples , *KILLER cells , *PATHOGENIC microorganisms , *LIGANDS (Biochemistry) , *POPULATION - Abstract
The functions of human NK cells in defense against pathogens and placental development during reproduction are modulated by interactions of killer cell Ig-like receptors (KIRs) with HLA-A, -B and -C class I ligands. Both receptors and ligands are highly polymorphic and exhibit extensive differences between human populations. Indigenous to southern Africa are the KhoeSan, the most ancient group of modern human populations, who have highest genomic diversity worldwide. We studied two KhoeSan populations, the Nama pastoralists and the ≠Khomani San hunter-gatherers. Comprehensive next-generation sequence analysis of HLA-A, -B, and -C and all KIR genes identified 248 different KIR and 137 HLA class I, which assort into ~200 haplotypes for each gene family. All 74 Nama and 78 ≠Khomani San studied have different genotypes. Numerous novel KIR alleles were identified, including three arising by intergenic recombination. On average, KhoeSan individuals have seven to eight pairs of interacting KIR and HLA class I ligands, the highest diversity and divergence of polymorphic NK cell receptors and ligands observed to date. In this context of high genetic diversity, both the Nama and the ≠Khomani San have an unusually conserved, centromeric KIR haplotype that has arisen to high frequency and is different in the two KhoeSan populations. Distinguishing these haplotypes are independent mutations in KIR2DL1, which both prevent KIR2DL1 from functioning as an inhibitory receptor for C2+ HLA-C. The relatively high frequency of C2+ HLA-C in the Nama and the ≠Khomani San appears to have led to natural selection against strong inhibitory C2-specific KIR. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
26. HIV-1 adaptation to NK cell-mediated immune pressure.
- Author
-
Elemans, Marjet, Boelen, Lies, Rasmussen, Michael, Buus, Søren, and Asquith, Becca
- Subjects
- *
KILLER cells , *IMMUNOGLOBULIN receptors , *HIV , *CYTOLOGY , *BLOOD cells - Abstract
The observation, by Alter et al., of the enrichment of NK cell “escape” variants in individuals carrying certain Killer-cell Immunoglobulin-like Receptor (KIR) genes is compelling evidence that natural killer (NK) cells exert selection pressure on HIV-1. Alter et al hypothesise that variant peptide, in complex with HLA class I molecules binds KIR receptors and either increases NK cell inhibition or decreases NK cell activation compared to wild type peptide thus leading to virus escape from the NK cell response. According to this hypothesis, in order for NK cells to select for an escape variant, an individual must carry both the KIR and an HLA ligand that binds the variant peptide. In this study we estimate the proportion of the population that is capable of selecting for escape variants and use both epidemiological modelling and a model-free approach to investigate whether this proportion explains the observed variant enrichment. We found that the fraction of individuals within whom the variant would have a selective advantage was low and was unable to explain the high degree of enrichment observed. We conclude that whilst Alter et al’s data is consistent with selection pressure, the mechanism that they postulate is unlikely. The importance of this work is two-fold. Firstly, it forces a re-evaluation of some of the clearest evidence that NK cells exert a protective effect in HIV-1 infection. Secondly, it implies that there is a significant aspect of immunology that is not understood: it is possible that KIRs bind much more widely than was previously appreciated; that a gene in linkage with the KIR genes is responsible for considerable peptide-dependent selection or that variant peptides are indirectly impacting KIR ligation. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
27. Human neutrophil kinetics: modeling of stable isotope labeling data supports short blood neutrophil half-lives.
- Author
-
Lahoz-Beneytez, Julio, Elemans, Marjet, Yan Zhang, Ahmed, Raya, Salam, Arafa, Block, Michael, Niederalt, Christoph, Asquith, Becca, and Macallan, Derek
- Subjects
- *
NEUTROPHILS , *DEUTERIUM oxide , *BLOOD , *STABLE isotopes , *BLOOD sugar , *BONE marrow - Abstract
Human neutrophils have traditionally been thought to have a short half-life in blood; estimates vary from 4 to 18 hours. This dogma was recently challenged by stable isotope labeling studies with heavy water, which yielded estimates in excess of 3 days. To investigate this disparity, we generated new stable isotope labeling data in healthy adult subjects using both heavy water (n = 4) and deuterium-labeled glucose (n = 9), a compound with more rapid labeling kinetics. To interpret results, we developed a novel mechanistic model and applied it to previously published (n = 5) and newly generated data. We initially constrained the ratio of the blood neutrophil pool to the marrow precursor pool (ratio = 0.26; from published values). Analysis of heavy water data sets yielded turnover rates consistent with a short blood half-life, but parameters, particularly marrow transit time, were poorly defined. Analysis of glucose-labeling data yielded more precise estimates of half-life (0.79 ± 0.25 days; 19 hours) and marrow transit time (5.80 ± 0.42 days). Substitution of this marrow transit time in the heavy water analysis gave a betterdefined blood half-life of 0.77 ± 0.14 days (18.5 hours), close to glucose-derived values. Allowing the ratio of blood neutrophils to mitotic neutrophilprecursors (R) to vary yieldedabest-fit valueof 0.19. Reanalysisof the previouslypublishedmodelanddata also revealed theorigin of their longestimates forneutrophilhalf-life: animplicitassumptionthatRis very large,which is physiologically untenable.We conclude that stable isotope labeling in healthy humans is consistent with a blood neutrophil half-life of less than 1 day. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
28. BIITE: A Tool to Determine HLA Class II Epitopes from T Cell ELISpot Data.
- Author
-
Boelen, Lies, O’Neill, Patrick K., Quigley, Kathryn J., Reynolds, Catherine J., Maillere, Bernard, Robinson, John H., Lertmemongkolchai, Ganjana, Altmann, Daniel M., Boyton, Rosemary J., and Asquith, Becca
- Subjects
- *
CD4 antigen , *HUMAN T cells , *HLA class II antigens , *EPITOPES , *BAYESIAN analysis , *IMMUNE response , *HUMAN leucocytes - Abstract
Activation of CD4+ T cells requires the recognition of peptides that are presented by HLA class II molecules and can be assessed experimentally using the ELISpot assay. However, even given an individual’s HLA class II genotype, identifying which class II molecule is responsible for a positive ELISpot response to a given peptide is not trivial. The two main difficulties are the number of HLA class II molecules that can potentially be formed in a single individual (3–14) and the lack of clear peptide binding motifs for class II molecules. Here, we present a Bayesian framework to interpret ELISpot data (BIITE: Bayesian Immunogenicity Inference Tool for ELISpot); specifically BIITE identifies which HLA-II:peptide combination(s) are immunogenic based on cohort ELISpot data. We apply BIITE to two ELISpot datasets and explore the expected performance using simulations. We show this method can reach high accuracies, depending on the cohort size and the success rate of the ELISpot assay within the cohort. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
29. Reconciling Estimates of Cell Proliferation from Stable Isotope Labeling Experiments.
- Author
-
Ahmed, Raya, Westera, Liset, Drylewicz, Julia, Elemans, Marjet, Zhang, Yan, Kelly, Elizabeth, Reljic, Rajko, Tesselaar, Kiki, de Boer, Rob J., Macallan, Derek C., Borghans, José A. M., and Asquith, Becca
- Subjects
- *
CELL proliferation -- Molecular aspects , *CELL proliferation , *MOLECULAR biology , *RADIOLABELING , *LYMPHOCYTES , *PHYSIOLOGY - Abstract
Stable isotope labeling is the state of the art technique for in vivo quantification of lymphocyte kinetics in humans. It has been central to a number of seminal studies, particularly in the context of HIV-1 and leukemia. However, there is a significant discrepancy between lymphocyte proliferation rates estimated in different studies. Notably, deuterated 2H2-glucose (D2-glucose) labeling studies consistently yield higher estimates of proliferation than deuterated water (D2O) labeling studies. This hampers our understanding of immune function and undermines our confidence in this important technique. Whether these differences are caused by fundamental biochemical differences between the two compounds and/or by methodological differences in the studies is unknown. D2-glucose and D2O labeling experiments have never been performed by the same group under the same experimental conditions; consequently a direct comparison of these two techniques has not been possible. We sought to address this problem. We performed both in vitro and murine in vivo labeling experiments using identical protocols with both D2-glucose and D2O. This showed that intrinsic differences between the two compounds do not cause differences in the proliferation rate estimates, but that estimates made using D2-glucose in vivo were susceptible to difficulties in normalization due to highly variable blood glucose enrichment. Analysis of three published human studies made using D2-glucose and D2O confirmed this problem, particularly in the case of short term D2-glucose labeling. Correcting for these inaccuracies in normalization decreased proliferation rate estimates made using D2-glucose and slightly increased estimates made using D2O; thus bringing the estimates from the two methods significantly closer and highlighting the importance of reliable normalization when using this technique. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
30. HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP.
- Author
-
Niederer, Heather A., Laydon, Daniel J., Melamed, Anat, Elemans, Marjet, Asquith, Becca, Masao Matsuoka, and Bangham, Charles R. M.
- Abstract
Background: HTLV-1 causes proliferation of clonal populations of infected T cells in vivo, each clone defined by a unique proviral integration site in the host genome. The proviral load is strongly correlated with odds of the inflammatory disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). There is evidence that asymptomatic HTLV-1 carriers (ACs) have a more effective CD8 + T cell response, including a higher frequency of HLA class I alleles able to present peptides from a regulatory protein of HTLV-1, HBZ. We have previously shown that specific features of the host genome flanking the proviral integration site favour clone survival and spontaneous expression of the viral transactivator protein Tax in naturally infected PBMCs ex vivo. However, the previous studies were not designed or powered to detect differences in integration site characteristics between ACs and HAM/TSP patients. Here, we tested the hypothesis that the genomic environment of the provirus differs systematically between ACs and HAM/TSP patients, and between individuals with strong or weak HBZ presentation. Methods: We used our recently described high-throughput protocol to map and quantify integration sites in 95 HAM/ TSP patients and 68 ACs from Kagoshima, Japan, and 75 ACs from Kumamoto, Japan. Individuals with 2 or more HLA class I alleles predicted to bind HBZ peptides were classified 'strong' HBZ binders; the remainder were classified 'weak binders'. Results: The abundance of HTLV-1-infected T cell clones in vivo was correlated with proviral integration in genes and in areas with epigenetic marks associated with active regulatory elements. In clones of equivalent abundance, integration sites in genes and active regions were significantly more frequent in ACs than patients with HAM/TSP, irrespective of HBZ binding and proviral load. Integration sites in genes were also more frequent in strong HBZ binders than weak HBZ binders. Conclusion: Clonal abundance is correlated with integration in a transcriptionally active genomic region, and these regions may promote cell proliferation. A clone that reaches a given abundance in vivo is more likely to be integrated in a transcriptionally active region in individuals with a more effective anti-HTLV-1 immune response, such those who can present HBZ peptides or those who remain asymptomatic. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
31. Quantification of HTLV-1 Clonality and TCR Diversity.
- Author
-
Laydon, Daniel J., Melamed, Anat, Sim, Aaron, Gillet, Nicolas A., Sim, Kathleen, Darko, Sam, Kroll, J. Simon, Douek, Daniel C., Price, David A., Bangham, Charles R. M., and Asquith, Becca
- Subjects
- *
HTLV-I , *T cell receptors , *IMMUNOLOGY , *MICROBIAL diversity , *CLONE cells - Abstract
Estimation of immunological and microbiological diversity is vital to our understanding of infection and the immune response. For instance, what is the diversity of the T cell repertoire? These questions are partially addressed by high-throughput sequencing techniques that enable identification of immunological and microbiological “species” in a sample. Estimators of the number of unseen species are needed to estimate population diversity from sample diversity. Here we test five widely used non-parametric estimators, and develop and validate a novel method, DivE, to estimate species richness and distribution. We used three independent datasets: (i) viral populations from subjects infected with human T-lymphotropic virus type 1; (ii) T cell antigen receptor clonotype repertoires; and (iii) microbial data from infant faecal samples. When applied to datasets with rarefaction curves that did not plateau, existing estimators systematically increased with sample size. In contrast, DivE consistently and accurately estimated diversity for all datasets. We identify conditions that limit the application of DivE. We also show that DivE can be used to accurately estimate the underlying population frequency distribution. We have developed a novel method that is significantly more accurate than commonly used biodiversity estimators in microbiological and immunological populations. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
32. Rates of CTL Killing in Persistent Viral Infection In Vivo.
- Author
-
Elemans, Marjet, Florins, Arnaud, Willems, Luc, and Asquith, Becca
- Subjects
- *
VIRUS diseases , *CYTOTOXIC T cells , *CELL-mediated cytotoxicity , *HIV infections , *BOVINE leukemia virus , *HTLV - Abstract
The CD8+ cytotoxic T lymphocyte (CTL) response is an important defence against viral invasion. Although CTL-mediated cytotoxicity has been widely studied for many years, the rate at which virus-infected cells are killed in vivo by the CTL response is poorly understood. To date the rate of CTL killing in vivo has been estimated for three virus infections but the estimates differ considerably, and killing of HIV-1-infected cells was unexpectedly low. This raises questions about the typical anti-viral capability of CTL and whether CTL killing is abnormally low in HIV-1. We estimated the rate of killing of infected cells by CD8+ T cells in two distinct persistent virus infections: sheep infected with Bovine Leukemia Virus (BLV) and humans infected with Human T Lymphotropic Virus type 1 (HTLV-1) which together with existing data allows us to study a total of five viruses in parallel. Although both BLV and HTLV-1 infection are characterised by large expansions of chronically activated CTL with immediate effector function ex vivo and no evidence of overt immune suppression, our estimates are at the lower end of the reported range. This enables us to put current estimates into perspective and shows that CTL killing of HIV-infected cells may not be atypically low. The estimates at the higher end of the range are obtained in more manipulated systems and may thus represent the potential rather than the realised CTL efficiency. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
33. Can Non-lytic CD8+ T Cells Drive HIV-1 Escape?
- Author
-
Seich al Basatena, Nafisa-Katrin, Chatzimichalis, Konstantinos, Graw, Frederik, Frost, Simon D. W., Regoes, Roland R., and Asquith, Becca
- Subjects
- *
CD8 antigen , *T cells , *GLYCOPROTEINS , *LYSINS , *ENZYMES - Abstract
The CD8+ T cell effector mechanisms that mediate control of HIV-1 and SIV infections remain poorly understood. Recent work suggests that the mechanism may be primarily non-lytic. This is in apparent conflict with the observation that SIV and HIV-1 variants that escape CD8+ T cell surveillance are frequently selected. Whilst it is clear that a variant that has escaped a lytic response can have a fitness advantage compared to the wild-type, it is less obvious that this holds in the face of non-lytic control where both wild-type and variant infected cells would be affected by soluble factors. In particular, the high motility of T cells in lymphoid tissue would be expected to rapidly destroy local effects making selection of escape variants by non-lytic responses unlikely. The observation of frequent HIV-1 and SIV escape poses a number of questions. Most importantly, is the consistent observation of viral escape proof that HIV-1- and SIV-specific CD8+ T cells lyse infected cells or can this also be the result of non-lytic control? Additionally, the rate at which a variant strain escapes a lytic CD8+ T cell response is related to the strength of the response. Is the same relationship true for a non-lytic response? Finally, the potential anti-viral control mediated by non-lytic mechanisms compared to lytic mechanisms is unknown. These questions cannot be addressed with current experimental techniques nor with the standard mathematical models. Instead we have developed a 3D cellular automaton model of HIV-1 which captures spatial and temporal dynamics. The model reproduces in vivo HIV-1 dynamics at the cellular and population level. Using this model we demonstrate that non-lytic effector mechanisms can select for escape variants but that outgrowth of the variant is slower and less frequent than from a lytic response so that non-lytic responses can potentially offer more durable control. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
34. Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humans.
- Author
-
Westera, Liset, Drylewicz, Julia, Braber, Ineke den, Mugwagwa, Tendai, Der Maas, Iris van, Kwast, Lydia, Volman, Thomas, Van de Weg-Schrijve, Elise H. R., Bartha, István, Spierenburg, Gerrit, Gaiser, Koos, Ackermans, Mariëtte T., Asquith, Becca, De Boer, Rob J., Tesselaar, Kiki, and Borghans, José A. M.
- Subjects
- *
T cells , *GENETIC regulation , *LABORATORY mice , *ISOTOPES , *LEUCOCYTES - Abstract
Quantitative knowledge of the turnover of different leukocyte populations is a key to our understanding of immune function in health and disease. Much progress has been made thanks to the introduction of stable isotope labeling, the state-of-the-art technique for in vivo quantification of cellular life spans. Yet, even leukocyte life span estimates on the basis of stable isotope labeling can vary up to 10-fold among laboratories. We investigated whether these differences could be the result of variances in the length of the labeling period among studies. To this end, we performed deuterated water-labeling experiments in mice, in which only the length of label administration was varied. The resulting life span estimates were indeed dependent on the length of the labeling period when the data were analyzed using a commonly used single-exponential model. We show that multiexponential models provide the necessary tool to obtain life span estimates - that are independent of the length of the labeling period. Use of a multiexponential model enabled us to reduce the gap between human T-cell life span estimates from 2 previously published labeling studies. This provides an important step toward unambiguous understanding of leukocyte turnover in health and disease. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
35. Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo.
- Author
-
Gillet, Nicolas A., Cook, Lucy, Laydon, Daniel J., Hlela, Carol, Verdonck, Kristien, Alvarez, Carolina, Gotuzzo, Eduardo, Clark, Daniel, Farre, Lourdes, Bittencourt, Achiléa, Asquith, Becca, Taylor, Graham P., and Bangham, Charles R. M.
- Subjects
- *
STRONGYLOIDIASIS , *HELMINTHIASIS , *PARASITIC diseases , *SKIN inflammation , *INFLAMMATION - Abstract
Human T-lymphotropic Virus-1 (HTLV-1) is a retrovirus that persists lifelong by driving clonal proliferation of infected T-cells. HTLV-1 causes a neuroinflammatory disease and adult T-cell leukemia/lymphoma. Strongyloidiasis, a gastrointestinal infection by the helminth Strongyloides stercoralis, and Infective Dermatitis associated with HTLV-1 (IDH), appear to be risk factors for the development of HTLV-1 related diseases. We used high-throughput sequencing to map and quantify the insertion sites of the provirus in order to monitor the clonality of the HTLV-1-infected T-cell population (i.e. the number of distinct clones and abundance of each clone). A newly developed biodiversity estimator called "DivE" was used to estimate the total number of clones in the blood. We found that the major determinant of proviral load in all subjects without leukemia/lymphoma was the total number of HTLV-1-infected clones. Nevertheless, the significantly higher proviral load in patients with strongyloidiasis or IDH was due to an increase in the mean clone abundance, not to an increase in the number of infected clones. These patients appear to be less capable of restricting clone abundance than those with HTLV-1 alone. In patients co-infected with Strongyloides there was an increased degree of oligoclonal expansion and a higher rate of turnover (i.e. appearance and disappearance) of HTLV-1-infected clones. In Strongyloides co-infected patients and those with IDH, proliferation of the most abundant HTLV-1+ T-cell clones is independent of the genomic environment of the provirus, in sharp contrast to patients with HTLV-1 infection alone. This implies that new selection forces are driving oligoclonal proliferation in Strongyloides co-infection and IDH. We conclude that strongyloidiasis and IDH increase the risk of development of HTLV-1-associated diseases by increasing the rate of infection of new clones and the abundance of existing HTLV-1+ clones. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
36. HTLV-1: Persistence and pathogenesis
- Author
-
Cook, Lucy B., Elemans, Marjet, Rowan, Aileen G., and Asquith, Becca
- Published
- 2013
- Full Text
- View/download PDF
37. In contrast to HIV, KIR3DS1 does not influence outcome in HTLV-1 retroviral infection
- Author
-
O’Connor, Geraldine M., Seich Al Basatena, Nafisa-Katrin, Olavarria, Viviana, MacNamara, Aidan, Vine, Alison, Ying, Qi, Hisada, Michie, Galvão-Castro, Bernardo, Asquith, Becca, and McVicar, Daniel W.
- Subjects
- *
HIV , *HEALTH outcome assessment , *HTLV-I , *ADULT T-cell leukemia , *PARAPARESIS , *RETROVIRUSES - Abstract
Abstract: While most carriers of human T-cell leukemia virus type 1 (HTLV-1) remain asymptomatic throughout their lifetime, infection is associated with the development of adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). The exact parameters that determine these outcomes are unknown but are believed to include host genetic factors that control the immune response to infection. Host response to fellow retroviridae member HIV is influenced by the expression of members of the Killer Immunoglobulin Receptor (KIR) family including KIR3DS1. In this study we examined the association of KIR3DS1 with the outcome of HTLV-1 infection in three geographically distinct cohorts (Jamaican, Japanese and Brazilian). Despite increased prevalence of KIR3DS1 in the HAM/TSP patients of the Jamaican cohort, we found no evidence for a role of KIR3DS1 in influencing control of proviral load or disease outcome. This suggests that unlike HIV, KIR3DS1-mediated regulation of HTLV-1 infection does not occur, or is ineffective. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
38. Viral Expression Directs the Fate of B Cells in Bovine Leukemia Virus-Infected Sheep.
- Author
-
Florins, Arnaud, de Brogniez, Alix, Elemans, Marjet, Bouzar, Amel-Baya, François, Carole, Reichert, Michal, Asquith, Becca, and Willems, Luc
- Subjects
- *
BOVINE leukemia virus , *RETROVIRUS genetics , *VIRUS diseases , *VIRAL replication , *IMMUNE response , *GENE expression - Abstract
The host immune response is believed to tightly control viral replication of deltaretroviruses such as human T-lymphotropic virus type 1 (HTLV-1) and bovine leukemia virus (BLV). However, this assumption has not been definitely proven in vivo. In order to further evaluate the importance of the immune response in the BLV model, we studied the fate of cells in which viral expression was transiently induced. Using a dual fluorochrome labeling approach, we showed that ex vivo induction of viral expression induces higher death rates of B cells in vivo. Furthermore, cyclosporine treatment of these animals indicated that an efficient immune response is required to control virus-expressing cells. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
39. Safety of long-term treatment of HAM/FSP patients with valproic acid.
- Author
-
Olindo, Stéphane, Belrose, Gildas, Gillet, Nicolas, Rodriguez, Sabrina, Boxus, Mathieu, Verlaeten, Olivier, Asquith, Becca, Bangham, Charles, Signate, Aïssatou, Smadja, Didier, Lezin, Agnes, Césaire, Raymond, and Willems, Luc
- Subjects
- *
HTLV , *PARAPARESIS , *NEURODEGENERATION , *LYSINE , *VALPROIC acid , *IMMUNE response , *DROWSINESS , *TREMOR - Abstract
HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a neurodegenerative disease of the central nervous system induced by human T-lymphotropic virus type 1. As a potential therapeutic approach, we previously suggested reducing the proviral load by modulating lysine deacetylase activity using valproic acid (VPA) and exposing virus-positive cells to the host immune response. We conducted a single-center, 2-year, open-label trial, with 19 HAM/TSP volunteers treated with oral VPA. Proviral load, CD38/HLA-DR expression, and CD8~ lysis efficiency were not significantly affected by VPA. Mean scores of HAM/TSP disabilIty did not differ between baseline and final visit. Walking Time Test increased significantly (> 20%) in 3 patients and was in keeping with minor VPA side effects (drowsiness and tremor). Walking Time Test improved rapidly after VPA discontinuation. We conclude that long-term treatment with VPA is safe in HAM/TSP. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
40. KIR2DL2 Enhances Protective and Detrimental HLA Class I-Mediated Immunity in Chronic Viral Infection.
- Author
-
Al Basatena, Nafisa-Katrin Seich, MacNamara, Aidan, Vine, Alison M., Thio, Chloe L., Astemborski, Jacquie, Usuku, Koichiro, Osame, Mitsuhiro, Kirk, Gregory D., Donfield, Sharyne M., Goedert, James J., Bangham, Charles R. M., Carrington, Mary, Khakoo, Salim I., and Asquith, Becca
- Subjects
- *
KILLER cells , *CELL receptors , *IMMUNITY , *T cells , *IMMUNE response , *VIRUS diseases - Abstract
Killer cell immunoglobulin-like receptors (KIRs) influence both innate and adaptive immunity. But while the role of KIRs in NK-mediated innate immunity is well-documented, the impact of KIRs on the T cell response in human disease is not known. Here we test the hypothesis that an individual's KIR genotype affects the efficiency of their HLA class I-mediated antiviral immune response and the outcome of viral infection. We show that, in two unrelated viral infections, hepatitis C virus and human T lymphotropic virus type 1, possession of the KIR2DL2 gene enhanced both protective and detrimental HLA class I- restricted anti-viral immunity. These results reveal a novel role for inhibitory KIRs. We conclude that inhibitory KIRs, in synergy with T cells, are a major determinant of the outcome of persistent viral infection. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
41. Why Don't CD8+ T Cells Reduce the Lifespan of SIV-Infected Cells In Vivo?
- Author
-
Elemans, Marjet, Seich al Basatena, Nafisa-Katrin, Klatt, Nichole R., Gkekas, Christos, Silvestri, Guido, and Asquith, Becca
- Subjects
- *
SWINE influenza , *VIREMIA , *T cells , *HIGHLY active antiretroviral therapy , *ANIMAL models in research - Abstract
In January 2010 two groups independently published the observation that the depletion of CD8+ cells in SIV-infected macaques had no detectable impact on the lifespan of productively infected cells. This unexpected observation led the authors to suggest that CD8+ T cells control SIV viraemia via non-lytic mechanisms. However, a number of alternative plausible explanations, compatible with a lytic model of CD8+ T cell control, were proposed. This left the field with no consensus on how to interpret these experiments and no clear indication whether CD8+ T cells operated primarily via a lytic or a non-lytic mechanism. The aim of this work was to investigate why CD8+ T cells do not appear to reduce the lifespan of SIV-infected cells in vivo. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
42. Quantification of the Relative Importance of CTL, B Cell, NK Cell, and Target Cell Limitation in the Control of Primary SIV-Infection.
- Author
-
Elemans, Marjet, Thiébaut, Rodolphe, Kaur, Amitinder, and Asquith, Becca
- Subjects
- *
T cells , *B cells , *KILLER cells , *HIV prevention , *RHESUS monkeys , *VIRAL load , *CELL death - Abstract
CD8S+ cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, B cells and target cell limitation have all been suggested to play a role in the control of SIV and HIV-1 infection. However, previous research typically studied each population in isolation leaving the magnitude, relative importance and in vivo relevance of each effect unclear. Here we quantify the relative importance of CTLs, NK cells, B cells and target cell limitation in controlling acute SIV infection in rhesus macaques. Using three different methods, we find that the availability of target cells and CD8S+ T cells are important predictors of viral load dynamics. If CTL are assumed to mediate this anti-viral effect via a lytic mechanism then we estimate that CTL killing is responsible for approximately 40% of productively infected cell death, the remaining cell death being attributable to intrinsic, immune (CD8S+ T cell, NK cell, B cell) -independent mechanisms. Furthermore, we find that NK cells have little impact on the death rate of infected CD4S+ cells and that their net impact is to increase viral load. We hypothesize that NK cells play a detrimental role in SIV infection, possibly by increasing T cell activation. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
43. In vivo Expression of Human T-lymphotropic Virus Type 1 Basic Leucine-Zipper Protein Generates Specific CD8+ and CD4+ T-Lymphocyte Responses that Correlate with Clinical Outcome.
- Author
-
Hilburn, Silva, Rowan, Aileen, Demontis, Maria-Antonietta, MacNamara, Aidan, Asquith, Becca, Bangham, Charles R. M., and Taylor, Graham P.
- Subjects
- *
HIV , *LEUCINE zippers , *T cells , *HEALTH outcome assessment , *ENZYME-linked immunosorbent assay , *VIRAL load , *LYMPHOCYTES - Abstract
Background. The roles of the human T-lymphotropic virus type 1 (HTLV-1) basic leucine zipper (HBZ) gene are not clearly understood. We examined CD8+ and CD4+ T cell responses to HBZ and compared these with Tax responses. Method. Interferon (IFN)-γ and interleukin (IL)-2-secreting T cells were detected by enzyme-linked immunosorbent spot (ELISpot) assays of freshly isolated peripheral blood mononuclear cells (PBMCs) stimulated with synthetic HBZ or Tax peptides. Ten patients with HTLV-1-associated myelopathy (HAM) and 20 asymptomatic HTLV-1 carriers (ACs), (10 high, 10 low viral load). Results. Of 30 study participants, 17 had detectable HBZ-specific CD4+ T cells and 12 had HBZ-specific CD8+ T cell responses. Detection of Tax-specific CD4+ T cells (IL-2- or IFN-γ-secreting) did not differ by disease status, but Tax-specific CD8+ T cell responses were more commonly detected in patients with HAM. HBZ-specific CD4+ or CD8+ T cells were less likely to be detected than Tax-specific T cells. IL-2-secreting Tax-specific CD8+ T cells, and IFN-γ-secreting Tax-specific CD4+ T cells were associated with HAM. Low viral load, asymptomatic HTLV-1 carriage was associated with IL-2-secreting CD8+ T cells specific for HBZ. Conclusion. HBZ protein is expressed in vivo in patients with HAM and in ACs. Our results are consistent with the idea that the T cell response to HBZ plays an important part in restricting HTLV-1 viral load. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
44. Spleen-Dependent Turnover of CD11b Peripheral Blood B Lymphocytes in Bovine Leukemia Virus-Infected Sheep.
- Author
-
Florins, Arnaud, Gillet, Nicolas, Asquith, Becca, Debacq, Christophe, Jean, Geneviève, Schwartz-Cornil, Isabelle, Bonneau, Michel, Burny, Arsène, Reichert, Michal, Kettmann, Richard, and Willems, Luc
- Subjects
- *
LYMPHOCYTES , *HOMEOSTASIS , *BOVINE leukemia virus , *VIRUS diseases in sheep , *LYMPHOID tissue , *CELL proliferation , *B cells , *SPLENECTOMY - Abstract
Lymphocyte homeostasis is determined by a critical balance between cell proliferation and death, an equilibrium which is deregulated in bovine leukemia virus (BLV)-infected sheep. We have previously shown that an excess of proliferation occurs in lymphoid tissues and that the peripheral blood population is prone to increased cell death. To further understand the mechanisms involved, we evaluated the physiological role of the spleen in this accelerated turnover. To this end, B lymphocytes were labeled in vivo using a fluorescent marker (carboxyfluorescein diacetate succinimidyl ester), and the cell kinetic parameters (proliferation and death rates) of animals before and after splenectomy were compared. We show that the enhanced cell death observed in BLV-infected sheep is abrogated after splenectomy, revealing a key role of the spleen in B-lymphocyte dynamics. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
45. Peripheral Blood B-Cell Death Compensates for Excessive Proliferation in Lymphoid Tissues and Maintains Homeostasis in Bovine Leukemia Virus-Infected Sheep.
- Author
-
Debacq, Christophe, Gillet, Nicolas, Asquith, Becca, Sanchez-Alcaraz, Maria Teresa, Florins, Arnaud, Boxus, Mathieu, Schwartz-Cornil, Isabelle, Bonneau, Michel, Jean, Geneviève, Kerkhofs, Pierre, Hay, Jack, Théwis, André, Kettmann, Richard, and Willems, Luc
- Subjects
- *
LYMPHOCYTES , *CELL proliferation , *LYMPHOID tissue , *HOMEOSTASIS , *LYMPH nodes , *BOVINE leukemia virus - Abstract
The size of a lymphocyte population is primarily determined by a dynamic equilibrium between cell proliferation and death. Hence, lymphocyte recirculation between the peripheral blood and lymphoid tissues is a key determinant in the maintenance of cell homeostasis. Insights into these mechanisms can be gathered from large-animal models, where lymphatic cannulation from individual lymph nodes is possible. In this study, we assessed in vivo lymphocyte trafficking in bovine leukemia virus (BLV)-infected sheep. With a carboxyfluorescein diacetate succinimidyl ester labeling technique, we demonstrate that the dynamics of lymphocyte recirculation is unaltered but that accelerated proliferation in the lymphoid tissues is compensated for by increased death in the peripheral blood cell population. Lymphocyte homeostasis is thus maintained by biphasic kinetics in two distinct tissues, emphasizing a very dynamic process during BLV infection. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
46. T-Cell Epitope Prediction: Rescaling Can Mask Biological Variation between MHC Molecules.
- Author
-
MacNamara, Aidan, Kadolsky, Ulrich, Bangham, Charles R. M., and Asquith, Becca
- Subjects
- *
EPITOPES , *ANTIGENS , *IMMUNE complexes , *PREVENTIVE medicine , *VACCINATION - Abstract
Theoretical methods for predicting CD8+ T-cell epitopes are an important tool in vaccine design and for enhancing our understanding of the cellular immune system. The most popular methods currently available produce binding affinity predictions across a range of MHC molecules. In comparing results between these MHC molecules, it is common practice to apply a normalization procedure known as rescaling, to correct for possible discrepancies between the allelic predictors. Using two of the most popular prediction software packages, NetCTL and NetMHC, we tested the hypothesis that rescaling removes genuine biological variation from the predicted affinities when comparing predictions across a number of MHC molecules. We found that removing the condition of rescaling improved the prediction software's performance both qualitatively, in terms of ranking epitopes, and quantitatively, in the accuracy of their binding affinity predictions. We suggest that there is biologically significant variation among class 1 MHC molecules and find that retention of this variation leads to significantly more accurate epitope prediction. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
47. In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection.
- Author
-
Zhang, Yan, Wallace, Diana L., de Lara, Catherine M., Ghattas, Hala, Asquith, Becca, Worth, Andrew, Griffin, George E., Taylor, Graham P., Tough, David F., Beverley, Peter C. L., and Macallan, Derek C.
- Subjects
- *
KILLER cells , *HOMEOSTASIS , *CELL division , *GLUCOSE , *VIRUS diseases - Abstract
Human natural killer (NK) cells form a circulating population in a state of dynamic homeostasis. We investigated NK cell homeostasis by labelling dividing cells in vivo using deuterium-enriched glucose in young and elderly healthy subjects and patients with viral infection. Following a 24-hr intravenous infusion of 6,6-D2-glucose, CD3– CD16+ NK cells sorted from peripheral blood mononuclear cells (PBMC) by fluorescence-activated cell sorter (FACS) were analysed for DNA deuterium content by gas chromatography mass spectrometry to yield minimum estimates for proliferation rate ( p). In healthy young adults ( n = 5), deuterium enrichment was maximal ∼ 10 days after labelling, consistent with postmitotic maturation preceding circulation. The mean (± standard deviation) proliferation rate was 4·3 ± 2·4%/day (equivalent to a doubling time of 16 days) and the total production rate was 15 ± 7·6 × 106 cells/l/day. Labelled cells disappeared from the circulation at a similar rate [6·9 ± 4·0%/day; half-life ( T½) < 10 days]. Healthy elderly subjects ( n = 8) had lower proliferation and production rates ( P = 2·5 ± 1·0%/day and 7·3 ± 3·7 × 106 cells/l/day, respectively; P = 0·04). Similar rates were seen in patients chronically infected with human T-cell lymphotropic virus type I (HTLV-I) ( P = 3·2 ± 1·9%/day). In acute infectious mononucleosis ( n = 5), NK cell numbers were increased but kinetics were unaffected ( P = 2·8 ± 1·0%/day) a mean of 12 days after symptom onset. Human NK cells have a turnover time in blood of about 2 weeks. Proliferation rates appear to fall with ageing, remain unperturbed by chronic HTLV-I infection and normalize rapidly following acute Epstein–Barr virus infection. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
48. Human T Cell Lymphotropic Virus (HTLV) Type-1-Specific CD8+ T Cells: Frequency and Immunodominance Hierarchy.
- Author
-
Goon, Peter K. C., Biancardi, Mix, Fast, Noam, Igakura, Tadahiko, Hanon, Emmanuel, Mosley, Angelina J., Asquith, Becca, Gould, Keith G., Marshall, Sara, Taylor, Graham P., and Bangham, Charles R. M.
- Subjects
- *
LYMPHOCYTES , *T cells , *VIRUSES , *ANTINEOPLASTIC agents , *ANTIVIRAL agents , *VIRUS inhibitors - Abstract
Human T cell lymphotropic virus type 1 (HTLV-1) causes HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). We used interferon-γ enzyme-linked immunospot assays with overlapping peptides spanning the entire HTLV-1 proteome to test whether the HTLV-1-specific CD8+ T cells differed significantly in frequency or immunodominance hierarchy between patients with HAM/TSP and asymptomatic carriers and whether the frequency correlated with provirus load. Tax was the immunodominant target antigen. There was no significant qualitative or quantitative difference in the HTLV-1-specific CD8+ T cell response between the 2 groups. Virus-specific CD8+ T cell frequency alone does not indicate the effectiveness of the cytotoxic T lymphocyte response in controlling provirus load at equilibrium. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
49. High Circulating Frequencies of Tumor Necrosis Factor Alpha- and Interleukin-2-Secreting Human T-Lymphotropic Virus Type 1 (HTLV-1)-Specific CD4[sup +] T Cells in Patients with HTLV-1-Associated Neurological Disease.
- Author
-
Goon, Peter K.C., Igakura, Tadahiko, Hanon, Emmanuel, Mosley, Angelina J., Asquith, Becca, Gould, Keith G., Taylor, Graham P., Weber, Jonathan N., and Bangham, Charles R.M.
- Subjects
- *
HIV , *TUMOR necrosis factors , *INTERLEUKIN-2 - Abstract
Significantly higher frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4[sup +] T cells were present in the peripheral blood mononuclear cells of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients than in those of asymptomatic carriers with similar provirus loads. The data suggest that HTLV-1-specific CD4[sup +] T cells play a role in the pathogenesis of HAM/TSP. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
50. Clonality, latency and integration of HTLV-1 in vivo.
- Author
-
Bangham, Charles, Cook, Lucy, Laydon, Daniel, Asquith, Becca, and Melamed, Anat
- Subjects
- *
HTLV-I , *VIRAL genetics - Abstract
An abstract of the article "Clonality, latency and integration of HTLV-1 in vivo," by Charles Bangham and colleagues is presented.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.